A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost biosimilar version of it is slated to hit the market this year.
The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...
Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.
AbbVie (ABBV) stock is in focus as the company files lawsuit over Medicare's decision to select its Botox therapy for prciing negotiations. Read more here.
The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...
Matt Rosenberg negotiated a $163,000 discount on a hospital bill using Claude for help — and says AI is giving patients more power.
In today’s issue: Our in-depth WP Intelligence report on Medicaid’s new approach to innovative yet pricey drugs. Botox ...
Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.
The Centers for Medicare & Medicaid Services just announced the next 15 brand-name medicines selected for Medicare’s drug price negotiation program, which mandates price reductions of at least 25%.
4don MSNOpinion
Meaningful steps on Medicare reform
Social Security and Medicare are by far the biggest contributors to our national debt. The federal government spent $1.6 ...
AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...
In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming price cuts under the Inflation Reduction Act (IRA), AbbVie is the late | The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results